Caspase-14-deficient mice are more prone to the development of parakeratosis

Journal of Investigative Dermatology

Volumn 133, Issue 3, 2013, Pages 742-750

  Hoste, Esther ^a,b   Denecker, Geertrui ^a,b   Gilbert, Barbara ^a,b   Van Nieuwerburgh, Filip ^b   Van Der Fits, Leslie ^c   Asselbergh, Bob ^a,b   De Rycke, Riet ^a,b   Hachem, Jean Pierre ^d   Deforce, Dieter ^b   Prens, Errol P ^e   Vandenabeele, Peter ^a,b   Declercq, Wim ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; CASPASE 14; IMIQUIMOD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; EPIDERMIS; FEMALE; KERATINOCYTE; MOUSE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 84873743485     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.350     Document Type: Article

References (38)

1. Ahn SK, Hwang SM, Jiang SJ et al. (1999) The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis. J Invest Dermatol 113: 189-95
2. Armstrong AW, Voyles SV, Armstrong EJ et al. (2011) A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 20: 544-9
3. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5: 699-711
4. Brady SP (2004) Parakeratosis. J Am Acad Dermatol 50: 77-84
5. Conrad C, Nestle FO (2006) Animal models of psoriasis and psoriatic arthritis: an update. Curr Rheumatol Rep 8: 342-7
6. Demerjian M, Hachem JP, Tschachler E et al. (2008) Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 172: 86-97
7. Denda M, Wood LC, Emami S et al. (1996) The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 288: 230-8
8. Denecker G, Hoste E, Gilbert B et al. (2007) Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9: 666-74
9. Eckhart L, Declercq W, Ban J et al. (2000) Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 115: 1148-51
10. Eckhart L, Fischer H, Tschachler E (2012) Mechanisms and emerging functions of DNA degradation in the epidermis. Front Biosci 17: 2461-75
11. Elias PM, Crumrine D, Rassner U et al. (2004) Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 122: 314-9
12. Fischer H, Stichenwirth M, Dockal M et al. (2004) Stratum corneum-derived caspase-14 is catalytically active. FEBS Lett 577: 446-50
13. Ghadially R, Reed JT, Elias PM (1996) Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107: 558-64
14. Hibino T, Fujita E, Tsuji Y et al. (2010) Purification and characterization of active caspase-14 from human epidermis and development of the cleavage site-directed antibody. J Cell Biochem 109: 487-97
15. Hoste E, Kemperman P, Devos M et al. (2011) Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol 131: 2233-41
16. Hsu S, Dickinson D, Borke J et al. (2007) Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp Dermatol 16: 678-84
17. Hvid M, Johansen C, Deleuran B et al. (2011) Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines-a possible link between reduced skin barrier function and inflammation?. Exp Dermatol 20: 633-6
18. Jarnik M, Kartasova T, Steinert PM et al. (1996) Differential expression and cell envelope incorporation of small proline-rich protein 1 in different cornified epithelia. J Cell Sci 109(Part 6): 1381-91
19. Kaiser WJ, Upton JW, Long AB et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471: 368-72
20. Kovalenko A, Kim JC, Kang TB et al. (2009) Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 206: 2161-77
21. Lamkanfi M, Declercq W, Depuydt B et al. (2003) The Caspase Family. Landes Bioscience/Kluwer Academic-Plenum Publishers: Georgetown/New York, p.40
22. Lee P, Lee DJ, Chan C et al. (2009) Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458: 519-23
23. Lippens S, Kockx M, Denecker G et al. (2004) Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. Am J Pathol 165: 833-41
24. Lippens S, Kockx M, Knaapen M et al. (2000) Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 7: 1218-24
25. Lippens S, VandenBroecke C, Van Damme E et al. (2003) Caspase-14 is expressed in the epidermis, the choroid plexus, the retinal pigment epithelium and thymic Hassall's bodies. Cell Death Differ 10: 257-9
26. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445: 866-73
27. Menon GK, Feingold KR, Moser AH et al. (1985) De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res 26: 418-27
28. Palamara F, Meindl S, Holcmann M et al. (2004) Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol 173: 3051-61
29. Payne R.W. (2011) Genstat Release 14 Reference Manual. Part 3: Procedure library PL21. VSN International: Oxford.
30. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17: 1063-72
31. Raymond AA, Mechin MC, Nachat R et al. (2007) Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol 156: 420-7
32. Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26: 415-23
33. Scharschmidt TC, Man MQ, Hatano Y et al. (2009) Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 124: 496-506. e1-6
34. Swindell WR, Johnston A, Carbajal S et al. (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One 6: e18266
35. van der Fits L, Mourits S, Voerman JS et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-45
36. Wagner EF, Schonthaler HB, Guinea-Viniegra J et al. (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6: 704-14
37. Wagner TL, Ahonen CL, Couture AM et al. (1999) Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol 191: 10-9
38. Yamamoto M, Kamata Y, Iida T et al. (2011) Quantification of activated and total caspase-14 with newly developed ELISA systems in normal and atopic skin. J Dermatol Sci 61: 110-7